In recent years, molecular biology studies have shown that mutations of tumor suppressor gene p53, Receptor activator of nuclear factor-κΒ ligand (RANKL), osteoprotegerin, and other genes may be related to the pathogenesis of bone tumors (12). The gene discussed is TNFSF11; the disease is bone neoplasm.